News Article

16 February 09

Report for the Pharmaceutical Oncology Initiative Group (POI)

Assessment and appraisal of oncology medicines: does NICE’s approach include all relevant elements? What can be learnt from international HTA experiences?

A copy of the executive summary of this report is available below.

If you wish to receive a copy of the full report, please contact Martina Garau, Economist on 020 7747 8867 or mgarau@ohe.org.

Downloads

POI Executive Summary
Feb 09